Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy - sprookjes - yvandenbroek - TriplyDB

Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy

Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy

http://www.wikidata.org/entity/Q30480164

about

Animal and in silico models for the study of sarcomeric cardiomyopathies The embryological basis of subclinical hypertrophic cardiomyopathy Research priorities in sarcomeric cardiomyopathies Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations Thin filament mutations: developing an integrative approach to a complex disorder Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers Non-Invasive Imaging for Congenital Heart Disease: Recent Innovations in Transthoracic Echocardiography.Transthoracic echocardiography in children and young adults with congenital heart disease Cardiomyopathies: Evolution of pathogenesis concepts and potential for new therapies.Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance.Cardiac myosin binding protein C insufficiency leads to early onset of mechanical dysfunction.A Small Molecule Inhibitor of Sarcomere Contractility Acutely Relieves Left Ventricular Outflow Tract Obstruction in Feline Hypertrophic Cardiomyopathy One-Month Global Longitudinal Strain Identifies Patients Who Will Develop Pacing-Induced Left Ventricular Dysfunction over Time: The Pacing and Ventricular Dysfunction (PAVD) Study.Cardiomyopathies in children Subtle abnormalities in contractile function are an early manifestation of sarcomere mutations in dilated cardiomyopathy.T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy A clinical approach to inherited hypertrophy: the use of family history in diagnosis, risk assessment, and management.Muscle dysfunction in hypertrophic cardiomyopathy: what is needed to move to translation?Personalized echocardiography: clinical applications of advanced echocardiography and future directions.Cardiac myosin-binding protein-C is a critical mediator of diastolic function.Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations.The role of imaging in the diagnosis and management of hypertrophic cardiomyopathy.Diastolic Dysfunction of Hypertrophic Cardiomyopathy Genotype-Positive Subjects Without Hypertrophy Is Detected by Tissue Doppler Imaging: A Systematic Review and Meta-Analysis.Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial.New Paradigms in Hypertrophic Cardiomyopathy: Insights from Genetics.Life-long tailoring of management for patients with hypertrophic cardiomyopathy : Awareness and decision-making in changing scenarios.Tropomyosin flexural rigidity and single ca(2+) regulatory unit dynamics: implications for cooperative regulation of cardiac muscle contraction and cardiomyocyte hypertrophy.Familial hypertrophic cardiomyopathy related E180G mutation increases flexibility of human cardiac α-tropomyosin.Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy.Noninvasive assessment of myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy.Deformation patterns in genotyped patients with hypertrophic cardiomyopathy.Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy.Relationship of Echocardiographic Z Scores Adjusted for Body Surface Area to Age, Sex, Race, and Ethnicity: The Pediatric Heart Network Normal Echocardiogram Database.The Cumulative Effects of the MYH7-V878A and CACNA1C-A1594V Mutations in a Chinese Family with Hypertrophic Cardiomyopathy.Hypertrophic cardiomyopathy mutation in cardiac troponin T (R95H) attenuates length-dependent activation in guinea pig cardiac muscle fibers.

P2860

Q26865437-B108F3E9-C6CF-449D-A020-270E9C0C7C9D Q27342687-4544CBB0-46C2-440E-B9FF-5C1436C8C6ED Q27694507-B1589E1E-8BDA-4A9C-9EEF-07EB0C267E79 Q28263306-DD0A4EAC-5CDA-4E33-972F-7503D57A9942 Q28287468-739BF316-95FD-4325-A7F0-D40C3A20B4AD Q28307606-F67BDE54-39DF-45B7-A665-F5A40AA4556D Q28730121-896F9EDB-262D-4799-8DBD-A9D2EC4992CC Q30448090-1B1D0509-73A4-42B8-8591-48BEF1315BAD Q30465854-51884C33-AFE5-4E66-8A6B-9CACDABE0987 Q33812953-8F78A1E6-0918-45E4-BA74-CEC6FD9A0A1B Q34629550-B2785C49-04FA-49E0-8F9C-8BCDC6506099 Q34999606-B1E986D3-6403-4544-902A-15C9CCD1324F Q35845452-E9C71E66-0ED5-46E6-83B1-03C29B039A52 Q35893509-7127202C-4CEB-4977-918A-95B61F7CED29 Q36223728-0CDCC4A9-ABF2-4D1B-91E0-AEB2973671F1 Q36251163-01A44069-2DD4-4531-8E50-AF09D53208F8 Q36660321-FB49720E-532D-48C1-BF07-6E3593245723 Q36823735-3BAF66CE-E67A-4A08-BD09-9B6576DAF5E8 Q37160724-9E23E1C6-2834-4258-B788-C2C959037F6A Q37504006-341FE5F0-7694-4ED0-9A24-1B00AA723425 Q37696227-21E712CE-B4D3-4296-B5AC-9206B90A40FB Q37818213-DCA1CB85-683E-4192-BA55-5B6DC93CD077 Q38179957-87BED663-A90A-4230-A031-A374CA2755B0 Q38336102-E8BB88F3-4CC3-436A-B46F-5CA14685E082 Q38633389-02976677-334B-493D-BFFB-78AF57F0030D Q38740990-55240018-3D96-4DF1-8833-3AF11E3E664F Q41101323-FF363B64-62E2-420C-9DD5-7B79843B9097 Q41626761-A987881D-18EE-4A3C-933A-A7BC3D86C493 Q41836826-7ECFCCC3-EFBE-4826-BFF6-13241C4F0162 Q42320941-A11A6CBF-944D-46A3-BAB4-41B34D50EC58 Q42559219-9260D8D1-C568-4EB2-A983-C71DDF9B67CA Q42727154-A0514AB9-CA34-453B-A821-30738CF325C7 Q44354566-A449FBBF-A861-4F8F-8517-C513E3CC74CE Q46009548-7C19F1FB-1ACC-4EED-99AB-52F16D8EF0C7 Q46029482-DDB29B8D-5905-4A1A-8451-6476C2A627A6 Q47109744-5D1B483D-27A0-4B06-A26B-5528858A3418 Q47140449-F48202D3-9D13-4C05-A12C-D37EBE38AB01 Q47595778-48D626D1-9166-4457-9135-650BB8EADCB1 Q47779489-7A0CA519-B490-45CB-9599-F7AB9E040269 Q47904402-B9E9E899-DA30-4A9B-8DCD-24E6A30F6490

P2860

Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy

http://www.wikidata.org/entity/Q30480164

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Echocardiographic strain imagi ...... in hypertrophic cardiomyopathy

@ast

Echocardiographic strain imagi ...... in hypertrophic cardiomyopathy

@en

type

label

Echocardiographic strain imagi ...... in hypertrophic cardiomyopathy

@ast

Echocardiographic strain imagi ...... in hypertrophic cardiomyopathy

@en

prefLabel

Echocardiographic strain imagi ...... in hypertrophic cardiomyopathy

@ast

Echocardiographic strain imagi ...... in hypertrophic cardiomyopathy

@en

P1433

Q30480164-98A80E14-7BB2-4271-A92C-478063699E2F

P1476

Q30480164-D21E67D9-0EB3-4F25-BE4A-053C3F487C05

P2093

Q30480164-147210EA-8363-423C-94E3-1D135548288E

Q30480164-357980AA-F170-4DF2-8D16-C3A3C2B874B4

Q30480164-58BE742A-5073-441C-9D67-6D8657658DF8

Q30480164-A7764B29-FAF4-4BB3-9DD8-EE1F028B612B

Q30480164-B695E935-2064-4DA3-A1D0-33CCBF07812A

Q30480164-D292A7DD-BE61-4B0D-B7F5-85E636DE4F6D

Q30480164-DB59BDFA-4506-4023-A23F-7CADEEA2AE87

Q30480164-ED33C75C-B712-4505-8266-060819D2FF00

P2860

Q30480164-00E1BD11-6C4B-47A4-BC8F-E5BE6DA08711

Q30480164-091B794A-00DD-4DC1-948F-43822CD4F074

Q30480164-139A6988-E6E6-4D50-B098-FC13EBD61C8F

Q30480164-13CEBED3-D40E-478E-A59F-76F62A39CCD5

Q30480164-1884A22A-5673-4EE4-A276-A6DE1660FAD5

Q30480164-206762EE-10A4-4EBC-9369-1FCA16B1D1B0

Q30480164-24275798-A4DA-43CC-9B12-99CC141E8097

Q30480164-3417B5FE-8683-43F7-A0A8-E8D314CA07A0

Q30480164-4BB0EA0F-50CE-4838-885F-943280E22AA9

Q30480164-7735DC0E-B6DD-4B64-8F81-19BC55210F3E

P304

Q30480164-1A7A9FD7-992A-40DC-8651-711D8551F8A6

P31

Q30480164-42C07F8A-051E-4688-85D8-EF989DBECDFE

P356

Q30480164-02CF37AB-0DA9-41D0-A7D8-5859D4011062

P433

Q30480164-0B5EC07C-893D-4395-8E8C-77697D0E02A5

P478

Q30480164-D33310E0-96E5-4B74-B38F-CB3010B7935D

P50

Q30480164-05E43D58-33FC-47CC-B974-6F692B25EECA

Q30480164-3DC1FED2-364E-4509-A65A-B81D2A454067

Q30480164-431843AF-EF03-45E1-B0C6-F1F43CCDF668

Q30480164-66191530-1DE9-4200-8D79-B93E48C99E80

Q30480164-D7A9D365-D613-4541-AE90-A3F10D5BD180

P577

Q30480164-8FAAAA91-94BF-4D42-BE77-DA91C2D25E46

P698

Q30480164-DDC3E70B-B447-48EA-B34A-F085281D76EC

P921

Q30480164-591D8605-856C-4D3A-9409-8907734FFFA0

P932

Q30480164-F9C3EB33-330D-4422-B177-65B46D14F118

P356

CIRCGENETICS.109.862128

P1433

Circulation: Cardiovascular Genetics

P1476

Echocardiographic strain imagi ...... in hypertrophic cardiomyopathy

@en

P2093

Allison L Cirino

http://www.w3.org/2001/XMLSchema#string

Barry J Maron

http://www.w3.org/2001/XMLSchema#string

Christian Carlsen

http://www.w3.org/2001/XMLSchema#string

E John Orav

http://www.w3.org/2001/XMLSchema#string

Faranak Farrohi

http://www.w3.org/2001/XMLSchema#string

Jose Rivero

http://www.w3.org/2001/XMLSchema#string

Michael Christiansen

http://www.w3.org/2001/XMLSchema#string

Ole Havndrup

http://www.w3.org/2001/XMLSchema#string

P2860

The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms

Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy

Altered crossbridge kinetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy

Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium

A mouse model of familial hypertrophic cardiomyopathy

Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy

The Genetic Basis for Cardiomyopathy

Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay.

Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy

The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model.

P304

314-321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCGENETICS.109.862128

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Paal S Andersen

Henning Bundgaard

Jens Jakob Thune

P577

2009-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20031602

http://www.w3.org/2001/XMLSchema#string

P921

echocardiography

P932

2773504

http://www.w3.org/2001/XMLSchema#string